• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rh 溶血病新生儿补充输血与换血的关系。

Top-up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions.

机构信息

Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Vox Sang. 2010 Jul 1;99(1):65-70. doi: 10.1111/j.1423-0410.2010.01307.x. Epub 2010 Mar 15.

DOI:10.1111/j.1423-0410.2010.01307.x
PMID:20331535
Abstract

OBJECTIVE

To study the effect of a restrictive guideline for exchange transfusion (ET) on the number of top-up transfusions in neonates with Rh hemolytic disease.

STUDY DESIGN

Retrospective study of all (near)-term neonates with Rh hemolytic disease admitted to our center between 2000 and 2008. In December 2005, policy changed from using liberal ET criteria to more restrictive ET criteria. We recorded the number of ETs and the number of top-up transfusions in the group of neonates before (group I, n = 156) and after (group II, n = 27) the guideline change.

RESULTS

The percentage of neonates requiring an ET decreased from 66% (103/156) in group I to 26% (7/27) in group II (P < 0.01). The percentage of neonates receiving a top-up transfusion increased from 68% (105/154) in group I to 81% (22/27) in group II (P = 0.25). The median number of top-up transfusions increased from 1 (interquartile range 0-2) in group I to 2 (interquartile range 1-3) in group II (P = 0.01).

CONCLUSION

In this study, restrictive ET criteria in neonates with Rh hemolytic disease lead to a reduction of the rate of ET but an increase in the number of top-up transfusions for neonatal anemia.

摘要

目的

研究换血治疗(exchange transfusion,ET)限制指南对 Rh 溶血病新生儿输血次数的影响。

研究设计

对 2000 年至 2008 年期间在我院住院的所有(近)足月 Rh 溶血病新生儿进行回顾性研究。2005 年 12 月,我们的治疗策略从使用宽松 ET 标准改为更为严格的 ET 标准。我们记录了在指南改变前(第 I 组,n = 156)和改变后(第 II 组,n = 27)新生儿 ET 次数和输血次数。

结果

第 I 组需要 ET 的新生儿比例从 66%(103/156)降至 26%(7/27)(P < 0.01),第 I 组接受输血的新生儿比例从 68%(105/154)增至 81%(22/27)(P = 0.25)。第 I 组输血中位数从 1(四分位间距 0-2)增至 2(四分位间距 1-3)(P = 0.01)。

结论

在本研究中,Rh 溶血病新生儿采用严格 ET 标准可降低 ET 使用率,但会增加新生儿贫血的输血次数。

相似文献

1
Top-up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions.Rh 溶血病新生儿补充输血与换血的关系。
Vox Sang. 2010 Jul 1;99(1):65-70. doi: 10.1111/j.1423-0410.2010.01307.x. Epub 2010 Mar 15.
2
Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.新生儿重度 RhC 溶血病与 RhD 溶血病的产后结局比较。
Transfusion. 2013 Jul;53(7):1580-5. doi: 10.1111/j.1537-2995.2012.03937.x. Epub 2012 Nov 1.
3
Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.接受和未接受宫内输血治疗的恒河猴溶血病的儿科结局
Am J Obstet Gynecol. 2008 Jan;198(1):54.e1-4. doi: 10.1016/j.ajog.2007.05.030.
4
[Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].[恒河猴溶血病住院新生儿的围产期管理及神经学结局]
Gynecol Obstet Fertil. 2008 Oct;36(10):984-90. doi: 10.1016/j.gyobfe.2008.07.012. Epub 2008 Sep 18.
5
Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease.与 RhD 溶血病相比,Kell 溶血病新生儿的换血和补充换血。
Vox Sang. 2011 Apr;100(3):312-6. doi: 10.1111/j.1423-0410.2010.01408.x. Epub 2010 Sep 17.
6
[Biochemical and hematometric effects of exchange transfusion in isoimmunized neonates].[换血疗法对同种免疫新生儿的生化和血液学影响]
Bol Med Hosp Infant Mex. 1993 Mar;50(3):167-76.
7
Severe hemolytic disease of the newborn due to anti-Cw.由抗Cw抗体引起的新生儿严重溶血病
Obstet Gynecol. 2005 Nov;106(5 Pt 2):1180-2. doi: 10.1097/01.AOG.0000164060.89842.a9.
8
Two-stage single-volume exchange transfusion in severe hemolytic disease of the newborn.新生儿重症溶血病的两阶段单容量换血疗法
J Matern Fetal Neonatal Med. 2012 Jul;25(7):1080-3. doi: 10.3109/14767058.2011.622008. Epub 2011 Oct 17.
9
[Current validity of the exchange transfusion intervention by the classic indication. Our 15 years' experience].[经典指征下换血疗法干预的当前有效性。我们15年的经验]
Minerva Pediatr. 1990 Apr;42(4):135-41.
10
Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.红细胞同种免疫性溶血病换血治疗后的新生儿发病率。
Neonatology. 2013;103(2):141-7. doi: 10.1159/000343261. Epub 2012 Dec 11.

引用本文的文献

1
Patient experience and burden of haemolytic disease of the foetus and newborn: a systematic review.胎儿和新生儿溶血病的患者体验与负担:一项系统综述
BMC Pregnancy Childbirth. 2025 Feb 4;25(1):114. doi: 10.1186/s12884-025-07208-9.
2
Erythrokinetic mechanism(s) causing the "late anemia" of hemolytic disease of the fetus and newborn.导致胎儿和新生儿溶血病“晚期贫血”的红细胞动力学机制。
J Perinatol. 2024 Jun;44(6):916-919. doi: 10.1038/s41372-024-01872-z. Epub 2024 Jan 12.
3
Iron Overload and Anemia in Rhesus Hemolytic Disease of Newborn: A Prospective Observational Study.
新生儿恒河猴溶血病中的铁过载与贫血:一项前瞻性观察研究。
Indian J Pediatr. 2024 Aug;91(8):848-850. doi: 10.1007/s12098-023-04962-6. Epub 2023 Nov 27.
4
Neonatal sepsis in alloimmune hemolytic disease of the fetus and newborn: A retrospective cohort study of 260 neonates.新生儿同种免疫性溶血病中新生儿败血症:260 例新生儿的回顾性队列研究。
Transfusion. 2023 Jan;63(1):117-124. doi: 10.1111/trf.17176. Epub 2022 Nov 5.
5
Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcome.严重 Rh 介导同种免疫性胎儿和新生儿溶血病的换血治疗:20 年发病情况、相关风险和结局概述。
Vox Sang. 2021 Oct;116(9):990-997. doi: 10.1111/vox.13090. Epub 2021 Mar 17.
6
Immunoglobulin for alloimmune hemolytic disease in neonates.新生儿同种免疫性溶血病用免疫球蛋白
Cochrane Database Syst Rev. 2018 Mar 18;3(3):CD003313. doi: 10.1002/14651858.CD003313.pub2.
7
Exchange Transfusion for Severe Neonatal Hyperbilirubinemia: 17 Years' Experience from Vojvodina, Serbia.严重新生儿高胆红素血症的换血疗法:来自塞尔维亚伏伊伏丁那的17年经验
Indian J Hematol Blood Transfus. 2016 Jun;32(2):208-14. doi: 10.1007/s12288-015-0534-1. Epub 2015 Apr 2.
8
Neonatal outcomes of pregnancies affected by haemolytic disease of the foetus and newborn and managed with intrauterine transfusion: a service evaluation.胎儿和新生儿溶血病并接受宫内输血治疗的妊娠的新生儿结局:一项服务评估
Blood Transfus. 2013 Oct;11(4):548-52. doi: 10.2450/2013.0288-12. Epub 2013 Jul 19.
9
Improving the management and outcome in haemolytic disease of the foetus and newborn.改善胎儿和新生儿溶血病的管理与治疗结果。
Blood Transfus. 2013 Oct;11(4):484-6. doi: 10.2450/2013.0147-13. Epub 2013 Jul 19.
10
Management of haemolytic disease of the foetus & newborn: steps to improve the outcomes.胎儿及新生儿溶血病的管理:改善结局的措施
Indian J Med Res. 2013;138(1):11-2.